论文信息 - A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer. - 字舞流文

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer.

M. Friedlander | C. Stringer | D. Rischin | B. Ma | K. Hancock | M. Messing | Gemma M. Matthys | J. Lager | J. Hodge